CONCORDBIO
Concord Biotech Limited
Healthcare · Biotechnology
Market price data is delayed by at least 15 minutes. Not for trading or investment decisions.
Fundamentals
Current Price
₹1,056.6
P/B Ratio
6.1
52W High
₹2,150.4
52W Low
₹987
Dividend Yield
1.02%
Profit Margin
26.97%
ROE
—
Debt / Equity
0
Sector
Healthcare
Industry
Biotechnology
Peer Comparison same NSE industry · top 10 by 1M return
Biotechnology Medical Researchas of 8 Apr 2026 close
| Symbol | Company | Price | P/B | RSI | 1M Ret | ROE | D/E |
|---|---|---|---|---|---|---|---|
| CONCORDBIOyou | Concord Biotech Limited | ₹1,049.8 | 6.06 | 25.2 | -10.7% | — | 0.00 |
| SPARC | Sun Pharma Advanced Research | ₹136.16 | -12.81 | 63.5 | +12.4% | — | — |
| WINDLAS | Windlas Biotech Limited | ₹787.75 | 3.10 | 70.3 | +7.7% | — | 0.06 |
| ARVEE | Arvee Laboratories (India) L | ₹153.89 | 5.49 | 49.3 | +0.5% | — | 0.03 |
| BIOCON | Biocon Limited | ₹349.8 | 1.68 | 38.8 | -10.2% | — | 0.50 |
Price Chart
Quarterly Results Last 4 quarters
| Metric | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|
| Revenue | ₹277.8 Cr | ₹247.1 Cr | ₹204.0 Cr | ₹409.6 Cr |
| Gross Profit | ₹212.0 Cr | ₹198.0 Cr | ₹158.9 Cr | ₹268.9 Cr |
| Operating Income | ₹80.2 Cr | ₹70.1 Cr | ₹43.6 Cr | ₹187.2 Cr |
| Net Income | ₹63.6 Cr | ₹63.1 Cr | ₹44.1 Cr | ₹140.4 Cr |
Values in INR Crore. Source: yfinance / NSE filings.
SWOT Analysis AI · news + fundamentals
SWOT not available.
Recent News Sentiment
No recent news for this stock.
Data sourced from yfinance and public NSE filings. Not investment advice.